Correlation Between Sovereign Metals and ASTELLAS PHARMA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sovereign Metals and ASTELLAS PHARMA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sovereign Metals and ASTELLAS PHARMA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sovereign Metals Limited and ASTELLAS PHARMA UNSPADR, you can compare the effects of market volatilities on Sovereign Metals and ASTELLAS PHARMA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sovereign Metals with a short position of ASTELLAS PHARMA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sovereign Metals and ASTELLAS PHARMA.

Diversification Opportunities for Sovereign Metals and ASTELLAS PHARMA

-0.78
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Sovereign and ASTELLAS is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Sovereign Metals Limited and ASTELLAS PHARMA UNSPADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ASTELLAS PHARMA UNSPADR and Sovereign Metals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sovereign Metals Limited are associated (or correlated) with ASTELLAS PHARMA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ASTELLAS PHARMA UNSPADR has no effect on the direction of Sovereign Metals i.e., Sovereign Metals and ASTELLAS PHARMA go up and down completely randomly.

Pair Corralation between Sovereign Metals and ASTELLAS PHARMA

Assuming the 90 days horizon Sovereign Metals Limited is expected to generate 2.34 times more return on investment than ASTELLAS PHARMA. However, Sovereign Metals is 2.34 times more volatile than ASTELLAS PHARMA UNSPADR. It trades about 0.07 of its potential returns per unit of risk. ASTELLAS PHARMA UNSPADR is currently generating about -0.02 per unit of risk. If you would invest  28.00  in Sovereign Metals Limited on August 25, 2024 and sell it today you would earn a total of  20.00  from holding Sovereign Metals Limited or generate 71.43% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Sovereign Metals Limited  vs.  ASTELLAS PHARMA UNSPADR

 Performance 
       Timeline  
Sovereign Metals 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Sovereign Metals Limited are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady basic indicators, Sovereign Metals reported solid returns over the last few months and may actually be approaching a breakup point.
ASTELLAS PHARMA UNSPADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ASTELLAS PHARMA UNSPADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's technical indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Sovereign Metals and ASTELLAS PHARMA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sovereign Metals and ASTELLAS PHARMA

The main advantage of trading using opposite Sovereign Metals and ASTELLAS PHARMA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sovereign Metals position performs unexpectedly, ASTELLAS PHARMA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ASTELLAS PHARMA will offset losses from the drop in ASTELLAS PHARMA's long position.
The idea behind Sovereign Metals Limited and ASTELLAS PHARMA UNSPADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance